FDA announces meetings on Moderna, J&J boosters and ‘mix and match’ booster shots
ROCHESTER, N.Y. (WHEC) — The U.S. Food and Drug Administration Oct. 1 announced meetings where its Vaccines and Related Biological Products Advisory Committee (VRBPAC) will discuss booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines.
The meetings are scheduled for Oct. 14 and 15.
Both vaccines are currently being used under emergency use authorization (EUA) for people 18 and older.
The VRBPAC will also hear presentations and discuss data on the use of a booster that is different from the brand of vaccine used for the initial series of shots, or the “mix and match” approach that the University of Rochester Medical Center has studied.
During the Oct. 14 meeting, the VRBPAC will discuss amending the Moderna shot’s EUA to include the use of a booster shot for people 18 and older.
During the Oct. 15 meeting, the VRBPAC will discuss amending the Johnson & Johnson shot’s EUA to include the use of a booster shot for people 18 and older and the use of “mix and match” booster shots.
During both days, there will be an open public hearing where the public can comment.